Loading clinical trials...
Loading clinical trials...
Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy: a Prospective Phase II Clinical Randomized Controlled Study
This is a prospective phase II clinical randomized controlled study, the purpose of this study is to assess whether superficial parotid lobe-sparing intensity-modulated radiotherapy (SPLS-IMRT) can decrease the incidence of xerostomia versus conventional IMRT (C-IMRT) in NPC patients.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Sun Yat-sen University
Guangzhou, Guangdong, China
Start Date
January 12, 2018
Primary Completion Date
November 6, 2019
Completion Date
August 17, 2021
Last Updated
August 25, 2021
90
ACTUAL participants
superficial parotid lobe-sparing intensity-modulated radiotherapy
RADIATION
Lead Sponsor
Sun Yat-sen University
NCT06980038
NCT06059261
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06636734